Cargando…

Investigation of in vitro absorption, distribution, metabolism, and excretion and in vivo pharmacokinetics of paromomycin: Influence on oral bioavailability

OBJECTIVE: The objective of this study is to investigate in vitro Caco2 permeability, metabolism and in vivo pharmacokinetic (PK) properties of paromomycin to develop an efficient dosage form with improved oral bioavailability. MATERIALS AND METHODS: For the purpose, Caco2 permeability assay, mouse...

Descripción completa

Detalles Bibliográficos
Autores principales:	K. Pinjari, M. Jakir S., Somani, Rahul, Gilhotra, Ritu M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754937/ https://www.ncbi.nlm.nih.gov/pubmed/29326490 http://dx.doi.org/10.4103/ijp.IJP_651_16

Ejemplares similares

Clinical Pharmacokinetics of Daprodustat: Results of an Absorption, Distribution, and Excretion Study With Intravenous Microtracer and Concomitant Oral Doses for Bioavailability Determination
por: Mahar, Kelly M., et al.
Publicado: (2021)

Pharmacokinetics, bioavailability, tissue distribution and excretion of tangeretin in rat
por: Hung, Wei-Lun, et al.
Publicado: (2017)

Pharmacokinetics, bioavailability, and excretion of ponazuril in piglets
por: Wang, Wenxiang, et al.
Publicado: (2022)

Pharmacokinetics, absorption, distribution, metabolism and excretion of the MEK inhibitor zapnometinib in rats
por: Füll, Yvonne, et al.
Publicado: (2022)

Pharmacokinetics, bioavailability, metabolism and excretion of δ-viniferin in rats
por: Mao, Ping, et al.
Publicado: (2016)

Pharmacokinetics, Bioavailability, Excretion and Metabolism Studies of Akebia Saponin D in Rats: Causes of the Ultra-Low Oral Bioavailability and Metabolic Pathway
por: Li, Pengfei, et al.
Publicado: (2021)

The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [(14)C]-BI 425809 in Healthy Males
por: Burkard, Ute, et al.
Publicado: (2021)

The oral bioavailability, excretion and cytochrome P450 inhibition properties of epiberberine: an in vivo and in vitro evaluation
por: Chen, Ning, et al.
Publicado: (2017)

Correction to: The Absolute Bioavailability, Absorption, Distribution, Metabolism, and Excretion of BI 425809 Administered as an Oral Dose or an Oral Dose with an Intravenous Microtracer Dose of [(14)C]‑BI 425809 in Healthy Males
por: Burkard, Ute, et al.
Publicado: (2022)

Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential
por: Schultze-Mosgau, Marcus-Hillert, et al.
Publicado: (2018)

Absorption, Distribution, Excretion, and Pharmacokinetics of (14)C-Pyronaridine Tetraphosphate in Male and Female Sprague-Dawley Rats
por: Park, Sang Hyun, et al.
Publicado: (2010)

Absorption, distribution, metabolism and excretion of molidustat in healthy participants
por: Lentini, Silvia, et al.
Publicado: (2020)

Absolute Bioavailability, Tissue Distribution, and Excretion of Erinacine S in Hericium erinaceus Mycelia
por: Hu, Jun-Hao, et al.
Publicado: (2019)

Pharmacokinetics and bioavailability of chromium malate and its influence on trace metals absorption after oral or intravenous administration
por: Feng, Weiwei, et al.
Publicado: (2018)

Bioavailability and pharmacokinetics of oral meloxicam in llamas
por: Kreuder, Amanda J, et al.
Publicado: (2012)

The pharmacokinetics, bioavailability and excretion of bergapten after oral and intravenous administration in rats using high performance liquid chromatography with fluorescence detection
por: Yu, Xie-an, et al.
Publicado: (2016)

Leishmanicidal Activity of Films Containing Paromomycin and Gentamicin Sulfate both In Vitro and In Vivo
por: Tolouei, S, et al.
Publicado: (2011)

Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis
por: Verrest, Luka, et al.
Publicado: (2023)

Absorption and Excretion of Antipyrine
Publicado: (1888)

Paromomycin Affects Translation and Vesicle-Mediated Trafficking as Revealed by Proteomics of Paromomycin –Susceptible –Resistant Leishmania donovani
por: Chawla, Bhavna, et al.
Publicado: (2011)

Absorption, distribution, metabolism, and excretion of [(14)C]‐dasotraline in humans
por: Chen, Yu‐Luan, et al.
Publicado: (2016)

Ex Vivo and in Vivo Study of Sucrosomial(®) Iron Intestinal Absorption and Bioavailability
por: Fabiano, Angela, et al.
Publicado: (2018)

Investigation of Intestinal Absorption and Excretion of Paracetamol in Streptozotocin-Induced Hyperglycemia
por: Mészáros, Petra, et al.
Publicado: (2022)

Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles
por: Baek, Miri, et al.
Publicado: (2012)

Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration
por: Cho, Wan-Seob, et al.
Publicado: (2013)

OR23-05 Human Absorption, Metabolism, Excretion, and Absolute Oral Bioavailability of (14)C-CRN00808, an Orally Bioavailable, Nonpeptide, Selective, Somatostatin Receptor 2 (sST2) Biased Agonist for the Treatment of Acromegaly
por: Madan, Ajay, et al.
Publicado: (2020)

Paromomycin is superior to metronidazole in Dientamoeba fragilis treatment
por: Burgaña, Ander, et al.
Publicado: (2019)

Polymorphisms in genes involved in the absorption, distribution, metabolism, and excretion of drugs in the Kazakhs of Kazakhstan
por: Iskakova, Aisha N., et al.
Publicado: (2016)

Physiologically Based Pharmacokinetic Modelling of Inhaled Nemiralisib: Mechanistic Components for Pulmonary Absorption, Systemic Distribution, and Oral Absorption
por: Miller, Neil A., et al.
Publicado: (2021)

The contribution of absorption of integral nanocrystals to enhancement of oral bioavailability of quercetin
por: Shen, Baode, et al.
Publicado: (2021)

Rilzabrutinib, a reversible covalent Bruton's tyrosine kinase inhibitor: Absorption, metabolism, excretion, and absolute bioavailability in healthy participants
por: Ucpinar, Sibel, et al.
Publicado: (2023)

Preclinical Absorption, Distribution, Metabolism, and Excretion of an Oral Amide Prodrug of Gemcitabine Designed to Deliver Prolonged Systemic Exposure
por: Wickremsinhe, Enaksha, et al.
Publicado: (2013)

Topical paromomycin for New World cutaneous leishmaniasis
por: Sosa, Néstor, et al.
Publicado: (2019)

Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Naringin in Aged Rats
por: Zeng, Xuan, et al.
Publicado: (2019)

Cryptosporidiosis in a renal transplant patient treated with paromomycin
por: Khalil-ur-Rahman,, et al.
Publicado: (2007)

Pharmacokinetics, Bioavailability, and Swallowing Safety With Riluzole Oral Film
por: Wymer, James, et al.
Publicado: (2022)

Pharmacokinetics, Tissue Distribution and Excretion of Isoalantolactone and Alantolactone in Rats after Oral Administration of Radix Inulae Extract
por: Xu, Renjie, et al.
Publicado: (2015)

Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose
por: Tsukamoto, Ikuko, et al.
Publicado: (2014)

Absorption, distribution, metabolism, and excretion of [(14)C]-labeled naloxegol in healthy subjects
por: Bui, Khanh, et al.
Publicado: (2015)

Geographical Variability in Paromomycin Pharmacokinetics Does Not Explain Efficacy Differences between Eastern African and Indian Visceral Leishmaniasis Patients
por: Verrest, Luka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_545snqlk1kc8tavhofkqv7p5ji